UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16
UNDER THE SECURITIES EXCHANGE ACT of 1934
For the Month of November 2020
333-206723
(Commission File Number)
P.V NANO CELL LTD.
(Translation of registrant’s name into English)
8
Hamasger Street
Migdal Ha’Emek, 2310102, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _________
EXPLANATORY NOTE
P.V. Nano Cell Ltd. (the “Company”) hereby furnishes the following document:
Notice of Annual General Meeting of Shareholders of the Company to be held on December 28, 2020.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 24, 2020 | P.V NANO CELL LTD. | ||
By: | /s/ Evyatar Cohen | ||
Name: | Evyatar Cohen | ||
Title: | Chief Financial Officer |
2